Global Biochips Market 2024 - By Growth Factors, Applications, Regional Analysis, Key Players And Forecast 2033
The biochips global market report
2024from The Business Research Company provides comprehensive market
statistics, including global market size, regional shares, competitor market
share, detailed segments, trends, and opportunities. This report offers an
in-depth analysis of current and future industry scenarios, delivering a
complete perspective for thriving in the industrial automation software market.
Biochips Market, 2024report by The
Business Research Company offers comprehensive insights into the current state
of the market and highlights future growth opportunities.
Market Size - The biochips market
size has grown rapidly in recent years. It will grow from $10.86 billion in
2023 to $12.62 billion in 2024 at a compound annual growth rate (CAGR) of
16.3%. The growth in the historic period
can be attributed to increased demand for personalized medicine, high
prevalence of chronic diseases, technological innovations, expanded
applications in drug discovery, growth in investments in research and
development, and supportive regulatory frameworks.
The biochips market size is
expected to see rapid growth in the next few years. It will grow to $23.18
billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be
attributed to increasing adoption in point-of-care diagnostics, expanding
applications in drug development, rising demand for personalized medicine,
advancements in microfluidics technology, growing investments in research and
development, expanding collaborations between biotechnology companies and academic
institutions, and emerging opportunities in agricultural biotechnology. Major
trends in the forecast period include advancements in microfluidics technology,
emphasis on developing biochips for liquid biopsy applications, rising demand
for multiplexed assays for simultaneous detection of multiple analytes,
integration of artificial intelligence for data analysis, and the emergence of
novel biochip platforms.
Order your report now for swift
delivery @ https://www.thebusinessresearchcompany.com/report/biochips-global-market-report
Scope Of Biochips Market
The Business Research Company's
reports encompass a wide range of information, including:
1. Market Size (Historic and
Forecast): Analysis of the market's historical performance and projections for
future growth.
2. Drivers: Examination of the key
factors propelling market growth.
3. Trends: Identification of
emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the
market into its primary segments and their respective performance.
5. Focus Regions and Geographies:
Insight into the most critical regions and geographical areas influencing the
market.
6. Macro Economic Factors:
Assessment of broader economic elements impacting the market.
Biochips Market Overview
Market Drivers -The increasing
adoption of personalized medicines is expected to propel the growth of the
biochips market going forward. Personalized medicine refers to tailoring
medical treatment to individual characteristics, such as genetics or lifestyle,
to optimize effectiveness and minimize adverse effects. The growing demand for
personalized medicine is driven by its potential to provide more effective
treatments, advancements in genomics, increasing disease complexity, and
regulatory support. Biochips aid in personalized medicine by allowing for
precise and individualized treatment plans tailored to a person's genetic
profile. For instance, in February 2024, according to the Personalized Medicine
Coalition, a US-based non-profit organization, the FDA approved 16 novel
personalized therapies for patients with rare diseases in 2023, compared to six
in 2022. Thus, the increasing adoption of personalized medicines is driving the
growth of the biochips market.
Market Trends - Major companies in
the biochips market are concentrating their efforts on developing cutting-edge
technologies like organ-on-a-chip platforms, aiming to revolutionize drug
discovery and development processes. Organ-on-a-chip platforms are advanced
microfluidic devices engineered to replicate the physiological characteristics
and functions of human organs in a scaled-down format. For instance, in April
2024, Boston Micro Fabrication (BMF), a US-based nanotechnology research
company, launched BMF Biotechnology Inc. BMF Biotechnology Inc. specializes in
Biochips, also known as organ-on-a-chip platforms, designed to cultivate
large-scale tissues in vitro. This innovation facilitates the accelerated
development of new drugs and cosmetics by providing a platform for testing and
research outside of the human body.
The biochips market covered in
this report is segmented –
1) By Type:
Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays,
Cell Arrays
2) By Technology:
Microarrays, Microfluidics
3) By Application: Drug
Discovery And Development, Agriculture, Genomics, Disease Diagnostics,
Proteomics, Other Applications
4) By End-User:
Biotechnology And Pharmaceutical Companies, Academic And Research Institutes,
Hospitals And Diagnostic Centers, Other End-Users
Get an inside scoop of the
biochips market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15737&type=smp
Regional Insights - North
America was the largest region in the biochips market in 2023. Asia-Pacific is
expected to be the fastest-growing region in the forecast period. The regions
covered in the biochips market report are Asia-Pacific, Western Europe, Eastern
Europe, North America, South America, Middle East, Africa.
Key Companies - Major companies
operating in the biochips market are Thermo Fisher Scientific Inc., Roche
Diagnostics International Ltd, Zoetis Inc., Agilent Technologies Inc.,
PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan
Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford
Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit
Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit
Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical
Inc., Dolomite Microfluidics, Biocartis NV
Table of Contents
1. Executive Summary
2. Biochips Market Characteristics
3. Biochips Market Trends And
Strategies
4. Biochips Market - Macro
Economic Scenario
5. Global Biochips Market Size and
Growth
..........................
32. Global Biochips Market
Competitive Benchmarking
33. Global Biochips Market
Competitive Dashboard
34. Key Mergers And Acquisitions
In The Biochips Market
35. Biochips Market Future Outlook
and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments
Post a Comment